References |
1.British Pharmacopoeia, 2016, The Stationery office British Pharmacopoeia.2.Brown and Lowbury ,1965..J. Clin. Pathol., 18: 752.3.European Pharmacopoeia, 2017, European Dept. for the Quality of Medicines.4.Goto, S. and Enomoto, S.,1970. Japan. J. Microbiol., 14; 65.5.Isenberg, H.D. Clinical Microbiology Procedures Handbook 2nd Edition.6.Japanese Pharmacopoeia, 2016.7.Jorgensen, J.H., Pfaller, M.A., Carroll, K.C., Funke, G., Landry, M.L., Richter, S.S and Warnock., D.W. (2015)Manual ofClinical Microbiology, 11th Edition. Vol. 1.8.King, Ward and Raney, 1954, J. Lab. Clin. Med., 44:301.9.Lowbury and Collins ,1955, J.Clin. Pathol., 8:47.10.Lowbury, 1951, J.Clin.Path., 4:66.11. Murray, P.R, Baron.J.H., Pfaller M.A., Jorgensen, J.H and YolkenR.H (Ed.) 2003, Manual of Clinical Microbiology,8thEd., American Society for Microbiology, Washington, D.C.12.The United States Pharmacopoeia, 2019, The United States Pharmacopeial Convention. Rockville, MD. |